Alivus Life Sciences Ltd.

The sales slipped to Rs. 4898.70 millions for the June 2022 quarter as against Rs. 5248.97 millions during the year-ago period.A humble growth in net profit of 7.75% reported in the quarter ended June 2022 to Rs. 1087.33  millions from Rs. 1009.13 millions.The Operating Profit of the company witnessed a decrease to 1562.61 millions from 1644.34 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202206	202106	% Var	202206	202106	% Var	202203	202103	% Var
Sales	4898.70	5248.97	-6.67	4898.70	5248.97	-6.67	21232.14	18851.65	12.63
Other Income	94.93	39.86	138.16	94.93	39.86	138.16	147.04	8.11	1713.07
PBIDT	1562.61	1644.34	-4.97	1562.61	1644.34	-4.97	6307.64	5918.85	6.57
Interest	1.35	205.50	-99.34	1.35	205.50	-99.34	279.62	875.47	-68.06
PBDT	1561.26	1438.84	8.51	1561.26	1438.84	8.51	6028.02	5043.38	19.52
Depreciation	98.79	89.19	10.76	98.79	89.19	10.76	378.77	333.94	13.42
PBT	1462.47	1349.65	8.36	1462.47	1349.65	8.36	5649.25	4709.44	19.96
TAX	375.14	340.52	10.17	375.14	340.52	10.17	1462.01	1193.63	22.48
Deferred Tax	12.85	18.09	-28.97	12.85	18.09	-28.97	85.74	66.17	29.58
PAT	1087.33	1009.13	7.75	1087.33	1009.13	7.75	4187.24	3515.81	19.10
Equity	245.05	215.61	13.65	245.05	215.61	13.65	245.05	19.60	1150.26
PBIDTM(%)	31.90	31.33	1.82	31.90	31.33	1.82	29.71	31.40	-5.38